Cargando…
Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort Study
Background: Ivermectin is a drug that has been shown to be active against coronavirus disease 19 (COVID-19) in previous studies. Healthcare personnel are highly exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Therefore, we decided to offer them ivermectin as a pre-...
Autores principales: | Morgenstern, Jose, Redondo, Jose N, Olavarria, Alvaro, Rondon, Isis, Roca, Santiago, De Leon, Albida, Canela, Juan, Tavares, Johnny, Minaya, Miguelina, Lopez, Oscar, Castillo, Ana, Placido, Ana, Cruz, Rafael, Merette, Yudelka, Toribio, Marlenin, Francisco, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405705/ https://www.ncbi.nlm.nih.gov/pubmed/34513523 http://dx.doi.org/10.7759/cureus.17455 |
Ejemplares similares
-
Prophylactic Role of Ivermectin in Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Workers
por: Behera, Priyamadhaba, et al.
Publicado: (2021) -
PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis
por: Sun, Hongru, et al.
Publicado: (2019) -
Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population‐based propensity score matching study
por: Tae, Bum Sik, et al.
Publicado: (2019) -
Impact of marital status at diagnosis on survival and its change over time between 1973 and 2012 in patients with nasopharyngeal carcinoma: a propensity score‐matched analysis
por: Xu, Cheng, et al.
Publicado: (2017) -
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco‐induced lung cancer
por: Fusco, Juan Pablo, et al.
Publicado: (2018)